Season 2

For the chronic disease community, 2022 is set to be a major year of health policy. On this episode, Republican and Democrat poli…

A doctor knows their patients’ needs best. But too often, insurance gets in the way. In an effort to lower costs, insurers someti…

Have you received an unfair medical bill? You’re not alone. Many patients have faced high bills that are simply incorrect, or eve…

Today’s medical research and development creates the cures of tomorrow. But it requires immense amounts of funding to develop saf…

The Senate faces a race to the end of the year with a mountain of healthcare policies on its plate. Taking center stage is the Ho…

Half of individuals with health insurance are covered by their employer. If you are in this group, this episode is a must-listen.…

Cold and flu season is here. If you are immunocompromised, respiratory infections pose an even greater risk. Antibiotics are a co…

This Veteran’s Day, hosts Terry and Dr. Bob explore potential federal policies to improve healthcare for U.S. veterans. Congressw…

Hosts Terry and Dr. Bob catch up with patient advocates following their virtual meetings on Capitol Hill. Patients Rising Now Pat…

No two patients are the same, so often care teams can’t predict a treatment outcome from one patient to the next. That’s where bi…

Congress promises to lower drug prices. But patients won’t see any cost savings at the pharmacy counter. We sort through the fact…

COVID-19 continues to put the most vulnerable at risk, including the elderly and those with chronic illnesses. At its peak, it fi…

Patients depend on the research and development cycle to produce innovative, life saving medicines for rare and chronic condition…

Numerous health policies are under debate in Congress. As Senators and Representatives hash out drug pricing legislation and more…

As Congress continues to debate solutions to lower healthcare costs, biosimilars are a promising option. But uptake of biosimilar…

President Biden outlines a new COVID-19 strategy, the U.S. Senate returns to Washington, and the House of Representatives debates…

Want greater access to your doctor at a lower price? It’s possible through direct primary care. This healthcare solution allows p…

What can Congress do to aid in the fight against ovarian cancer? If reauthorized, Johanna’s Law would increase funding for ovaria…

Kids across the country are headed back to school. But as the Delta variant spreads, what should families living with chronic dis…

What’s the purpose of a patent? In the pharmaceutical industry, it helps manufacturers reinvest in new research and development t…

Premiums, deductibles, and copays continue to rise as insurance companies grow fat through mergers and monopolies. Host Terry Wil…

The Delta variant, a breakdown of the FDA’s accelerated approval process, and how pink socks are bringing together patient advoca…

Opioid overdoses are rising as the COVID-19 pandemic continues. In 2020, overdose deaths rose by 30%. However, many chronic disea…

The high price tag for a new Alzheimer’s drug has fueled the ongoing drug price debate. But will patients really pay sticker pric…

Access to all of your health data - MRIs, screenings, and lab results - could be right at your fingertips. COVID-19 put healthcar…

Patients depend on safety and accuracy of medical equipment. If they’re improperly repaired, it could derail a patient’s healthca…

Doctor’s visits, tests, procedures and therapies are just one part of a healthcare journey. Knowing and understanding the laws th…

Drama continues to unfold following the FDA’s controversial approval of a new Alzhiemer’s treatment. Members of the FDA’s advisor…

A new FDA-approved drug for Alzheimer’s signals a breakthrough in innovation for patients and caregivers, but has raised doubts f…

Following a pandemic that exposed disparities, and failures to patients with chronic disease, now is the time for lawmakers and t…

Can you tell the difference between an advertising claim and research-backed statistics? For chronic disease patients who take su…

More than 60 million Americans live with allergies or asthma. COVID-19 brought much needed attention to lung and respiratory chal…

Demands for mental and behavioral health services are on the rise. These services represented nearly half of all telehealth claim…

When it comes to saving a buck, rare and chronic disease patients are too often put on the chopping block. Accelerated approval d…

Patients rely on access to a broad range of innovative and effective medications to find a treatment option that best suits them.…

April is Donate Life Month, and we examine many challenges facing organ transplant recipients. Amidst the physical and emotional …

The FDA’s Acting Commissioner Dr. Janet Woodcock brings listeners inside the FDA. While the agency’s hands are full with a global…

The most effective treatments are often out of reach for patients. Big news came from the FDA announcing the approval of CAR-T th…

You may have seen Johns Hopkins Hospital surgeon Dr. Marty Makary all over the national news this week, and he also joins the Pat…

We conclude our series on lupus with a trip to the doctor’s office, where rheumatologist Dr. Mark Box delves into the clinical si…

This week, the Institute for Clinical and Economic Review (ICER) deliberates the fate of insurance coverage for patients with lup…

When a chronic condition prevents you from working, you might find yourself filling out a disability claim. But what happens when…

If you have trouble adhering to your medication regimen or know you need to eat healthier, but are overwhelmed, tiny habits may b…

COVID-19 has caused people to delay important cancer screenings and medical appointments. Coupled with the rising rates of colon …

Rare Disease Day is February 28. New and exciting medical innovations and drug therapies for rare disease abound, but accessing t…

Minority communities are underrepresented in healthcare leadership roles. By dismantling systemic barriers, the entire healthcare…

Digital tech became a major healthcare tool during the pandemic. And AI-powered prescription drug apps are leading the charge in …

Underserved communities are at higher risk for COVID, but they’re getting vaccinated at a slower pace. How do we correct a health…

Congress may soon revisit legislation to tackle the high costs of prescription drugs under Medicare. But drug pricing is never a …

Vaccine distribution is off to a rocky start. While some states are exceeding expectations, others continue to lag behind. This w…